BioSimilars

us-based-oncobiologics-and-china-based-zhejiang-huahai-pharma-are-looking-to-grab-a-chunk-of-the-global-usd40-billion-biosimilars-market

Huahai, Oncobiologics enter generics partnership

  • China
  • |
  • News

Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for the development, manufacture and commercialization of biosimilar monoclonal antibody products. The scope of the agreement... Read more

pfenex-agila-biotech-joint-venture-jv-to-develop-manufacture-and-commercialize-six-biosimilar-products

Pfenex, Agila JV to develop biosimilar


  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: US-based Pfenex and India-based Agila Biotech, a subsidiary of Strides Arcolab, entered into a joint venture (JV)... Read more

commercialization-agreement

Samsung Bioepis, Merck in biosimilars deal


  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Seoul-based Samsung Bioepis and MSD, known as Merck in the US and Canada, have entered into an agreement to develop... Read more

dr-gautam-daftary-managing-director-bharat-serums-and-vaccines-india

Dr Gautam Daftary: The Indian biologics pioneer

  • India
  • |
  • Influencers
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world and has carved... Read more

the-4th-annual-biosimilars-conference-will-be-held-from-march-6-8-2013-at-mumbai-india

Conference to focus on biosimilars landscape

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Bangalore: During the past several years, biosimilars has been drawing the market's attention due to the upcoming patent cliff. There is... Read more

frost-sullivan-south-korea-is-estimated-to-earn-revenues-of-usd89

F&S: S. Korea will be biosimilars leader by 2020

  • Korea
  • |
  • Analysis
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: Since South Korea introduced a regulatory pathway for manufacturing biologics in 2009, the government has raised its stakes... Read more

catalent-umn-collaborate-for-biosimilars

Catalent, UMN collaborate for biosimilars

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Catalent Pharma Solutions and UMN Pharma announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar... Read more

lg-life-sciences-and-mochida-pharma-join-hands-for-biosimilar-development-in-s-korea-and-japan

LG to co-develop biosimilars with Mochida

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: LG Life Sciences (LGLS) and Mochida Pharmaceutical have finalized the agreement to collaborate during the clinical trials and... Read more

aet-biotech-and-bioxpress-therapeutics-to-jointly-develop-biosimilar-version-of-the-tnf-inhibitor-monoclonal-antibody-mab-adalimumab

AET, BioXpress enter deal for cancer monoclonal antibody

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AET BioTech, the separate biosimilars business within the generic drug developer Alfred E Tiefenbacher (AET) Group and BioXpress... Read more

us-biosimilars-market-to-be-usd9-bn-by-2020

US biosimilars market to be $9 bn by 2020

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by global business intelligence firm GBI Research has highlighted that the massive potential for pharmaceuticals... Read more

india-biosimilar-guidelines

Biosimilars guidelines: A step in the right direction for India

  • India
  • |
  • Analysis
  • |
  • By Narayan Kulkarni
  • |
  • 0 Comment

The announcement of the new biosimilars guidelines, "Guidelines on Similar Biologics: Regulatory Requirements for Marketing Authorization... Read more

biosimilars-clinical-trial

Malaysian firm Duopharma forays into biosimilars

  • Malaysia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Malaysia's chemical company Duopharma has tied up with Korea's PanGen Biotech to pioneer a clinical trial of Erythropoietin (EPO)... Read more

Previous 1

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X